[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

International Flavors & Fragrances (IFF)

International Flavors & Fragrances (IFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Flavors & Fragrances is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. It has 4 business units: Nourish, Scent, Health & Biosciences and Pharma Solutions; comprising 3 platforms: Ingredients, Flavors & Food Designs. Ingredients provide texturizing solutions to the food industry, food protection solutions for food and beverage products, specialty soy & pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds & natural taste solutions, and value-added spices and seasoning ingredients. Food Designs offer savory solution products. Health & Biosciences includes, Health, Cultures & Food Enzymes, Home & Personal Care, Animal Nutrition, Grain Processing and Microbial Control, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Pharma Solutions produces cellulosics and alginates-based pharma excipients.

Fiscal Year End Date: 12/31

(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Sales 2,741,000 2,589,000 2,694,000 2,764,000 2,843,000
Sales Growth +5.87% -3.90% -2.53% -2.78% +2.60%
Net Income 169,000 5,000 40,000 612,000 -1,018,000
Net Income Growth +3,280.00% -87.50% -93.46% +160.12% -2,113.04%
(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Total Assets 25,144,000 25,539,000 25,768,000 26,121,000 28,265,000
Total Assets Growth -1.55% -0.89% -1.35% -7.59% -1.40%
Total Liabilities 10,991,000 11,353,000 11,495,000 11,685,000 15,052,000
Total Liabilities Growth -3.19% -1.24% -1.63% -22.37% +2.01%
(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Operating Cash Flow 257,000 850,000 532,000 368,000 127,000
Operating Cash Flow Growth -69.76% +59.77% +44.57% +189.76% -88.13%
Net Cash Flow -28,000 119,000 150,000 345,000 179,000
Change in Net Cash Flow -123.53% -20.67% -56.52% +92.74% +167.80%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.